Arch Therapeutics Inc is a development-stage biotechnology company... Show more
Industry Biotechnology
A.I.dvisor tells us that ARTH and EDSA have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARTH and EDSA's prices will move in lockstep.
Ticker / NAME | Correlation To ARTH | 1D Price Change % | ||
---|---|---|---|---|
ARTH | 100% | N/A | ||
EDSA - ARTH | 21% Poorly correlated | -3.41% | ||
HRMY - ARTH | 20% Poorly correlated | +1.86% | ||
BIVI - ARTH | 13% Poorly correlated | +6.00% | ||
APLIF - ARTH | 12% Poorly correlated | +12.73% | ||
BETRF - ARTH | 5% Poorly correlated | +25.49% | ||
More |